Suchergebnisse - "Hoy, Jennifer F"

PubPharm (5)

1

Switch from tenofovir disoproxil fumarate to raltegravir is not associated with weight gain over 96 weeks

enthalten in: AIDS (London, England) | 2020

von Carr, M. | Richardson, R. | Tong, W. | +4

2

Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection

enthalten in: JAMA | 2019

von Traeger, M. | Cornelisse, V. | Asselin, J. | +29

CommentIn: JAMA. 2019 Apr 9;321(14):1356-1358. - PMID 30964514

3

Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV

enthalten in: AIDS (London, England) | 2018

von Hoy, J. | Richardson, R. | Ebeling, P. | +6

4

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2013

von Matthews, G. | Seaberg, E. | Avihingsanon, A. | +12

5

Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine

enthalten in: PloS one | 2012

von Haskelberg, H. | Hoy, J. | Amin, J. | +4

1
[1]